Tricida Secures $55,000,000 Series C Financing

  • Feed Type
  • Date
    7/26/2016
  • Company Name
    Tricida
  • Mailing Address
    7000 Shoreline Court South San Francisco, CA 94080 USA
  • Company Description
    Tricida, Inc. is an innovative startup company focused on the discovery and clinical development of novel therapeutics to address renal, metabolic and cardiovascular disease.
  • Website
    http://www.tricida.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $55,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    The financing round will enable late-stage trials of first-in-class clinical candidate TRC101 in patients with kidney disease.
  • M&A Terms
  • Venture Investor
    Longitude Capital Management
  • Venture Investor
    Vivo Capital
  • Venture Investor
    OrbiMed
  • Venture Investor
    Limulus Venture Partners
  • Venture Investor
    Sibling Capital Ventures

Trending on Xconomy